Gastric secretions were studied in rats by pyloric ligation in vivo. The effects of epidermal growth factor (EGF) administered s.c. on gastric secretion were evaluated at different stages of development (8, 14, 20 and 30 postnatal days). The rates of fluid, protein and acid outputs were very low in developing rats but increased in maturing rats. The rate of acid output in 8-day-old rats (3.83 ± 1.16) was not different from that in 14-day-old rats (4.84 ± 0.99), whereas the rate of acid output in 20-day-old rats was 11- fold greater than that in 14-day-old rats, and it was 21-fold greater in 30- day-old rats. Subcutaneous administration of 30 μg/kg b.wt. of EGF significantly suppressed the gastric secretion of fluid, protein and acid in 20- and 30-day-old rats. In 30-day-old rats, acid output was 85% lower at 1 hr after EGF administration and in 20-day-old rats it was 85% lower at 2 hr and 50% lower at 3 hr. Interestingly, EGF had no effect on basal gastric secretions in 8- and 14-day-old rats; EGF also had no effect on the gastric acid output that was stimulated by pentagastrin administration in 14-day-old rats. In 20-day-old rats, inhibitory effects of EGF lasted for 3 hr before gastric secretions rebounded to normal levels, but inhibition lasted for only 1 hr in 30-day-old rats. EGF was nearly 15-fold more potent in 20-day-old rats than in 30-day-old; the A50 (95% C.L.) values for EGF in 20- and 30- day-old rats were 7.5 (4.6-12.4) and 117.3 (77.2-168.5) μg/kg b.wt., respectively. EGF up to 950 μg/kg b.wt. showed no effect in 8- and 14-day- old rats. EGF receptors in gastric mucosal membranes, as analyzed by radioligand binding showed no age-related differences in their K(d) values, whereas maximum binding values in membranes prepared from 20-day-old rats was significantly greater than those in membranes prepared from 8-, 14- or 30- day-old rats. These results demonstrate ontogenic differences in the potency and efficacy of EGF in inhibiting gastric secretions in rats.
|Original language||English (US)|
|Number of pages||8|
|Journal||Journal of Pharmacology and Experimental Therapeutics|
|State||Published - Jan 1 1993|
ASJC Scopus subject areas
- Molecular Medicine